ホーム › 大腸癌 › カリフォルニア州 › San Francisco
San Francisco、CAにおける大腸癌の臨床試験
San Franciscoとその周辺地域（約30マイル以内）の拠点で、大腸癌に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
被験者募集中第3相
- UCSF at China Basin, San Francisco
- UCSF at Mount Zion, San Francisco
- UCSF at Parnassus, San Francisco
- 他1件
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
被験者募集中第2/3相
- Local Institution - 0317, San Francisco
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
被験者募集中第1/2相
- University of California, San Francisco (UCSF), San Francisco
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
被験者募集中第3相
- Clinical Study Site, San Francisco
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
被験者募集中第1相
- UCSF, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
被験者募集中第1/2相
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
被験者募集中
- University of California, San Francisco, San Francisco
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
被験者募集中第1相
- UCSF, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
被験者募集中第1/2相
- University of California San Francisco Cancer Center, San Francisco
LYL273 for Patients With Relapsed or Refractory mCRC
被験者募集中第1/2相
- University of California San Francisco Medical Center, San Francisco
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
被験者募集中第1相
- University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of MGC028 in Participants With Advanced Solid Tumors
被験者募集中第1相
- UCSF - Helen Diller Family Cancer Center, San Francisco
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
被験者募集中第1/2相
- University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Kaiser Permanente-San Francisco, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
被験者募集中第1/2相
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Multicenter Cancer Biospecimen Collection Study
被験者募集中観察研究
- Curebase, San Francisco
A Study of IBI363 in Subjects with Advanced Solid Malignancies
被験者募集中第2相
- University of California, San Francisco (UCSF), San Francisco
他の都市における大腸癌の試験
- Houston, TX102件の研究
- New York City, NY78件の研究
- Nashville, TN69件の研究
- Boston, MA63件の研究
- Los Angeles, CA59件の研究
- Arlington, VA52件の研究
- St. Louis, MO50件の研究
- San Antonio, TX46件の研究
- Philadelphia, PA44件の研究
- Grand Rapids, MI40件の研究
- Baldwin Park, CA37件の研究
- Chicago, IL34件の研究
San Franciscoにおける他の研究
- 前立腺がん45件の研究
- 乳がん43件の研究
- 非小細胞肺癌36件の研究
- がん（全種類）35件の研究
- 心不全29件の研究
- 転移性癌28件の研究
- 肺がん22件の研究
- 悪性黒色腫22件の研究
- 膵臓がん20件の研究
- 卵巣がん19件の研究
- 心血管疾患18件の研究
- 膠芽腫17件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。